Picture EBD Group BIO-Europe Spring 2019 BES Wien Vienna Austria 600x60px
Document › Details

PureTech Health plc. (5/31/16). "Press Release: PureTech to Present at the Jefferies 2016 Healthcare Conference in New York". Boston, MA.

Organisations Organisation PureTech Health plc (LSE: PRTC)
  Group PureTech Health (Group)
  Organisation 2 FTI Consulting, London (Aldersgate)
  Group FTI Consulting (Group)
Products Product Jefferies 2016 Global Healthcare Conference New York
  Product 2 BIOTECH
Index term Index term PureTech Health–Leucadia: investor conference, 201606 supply service PureTech presents at Jefferies Healthcare Conference in New York
Persons Person Zohar, Daphne (PureTech Health 2016 CEO)
  Person 2 Atwell, Ben (FTI Consulting 201303)

PureTech Health plc ("PureTech" or the "Company", LSE: PRTC), a cross-disciplinary healthcare company developing novel medicines focused on the brain, gut and immune system, today announces that Daphne Zohar, PureTech's Chief Executive Officer, will be presenting at the Jefferies 2016 Healthcare Conference in New York, NY being held on June 7-10, 2016.

PureTech's presentation is scheduled for Thursday 9 June 2016 at 9:30 am EDT and will be followed by a breakout session.

About PureTech Health

PureTech Health (PureTech Health plc, PRTC.L) is a cross-disciplinary healthcare company focused on areas of growing scientific and technical insights that it believes are at an important inflection point, including the central nervous, gastro-intestinal and immune systems, and the interactions and signalling between them. PureTech has a pipeline of more than 30 programmes and has approximately 20 clinical studies across its pipeline, targeting multi-billion dollar market opportunities. PureTech's advanced programs include five with human proof-of-concept and multiple with pivotal or registration study readouts in the next two years. PureTech has over 220 patents and patent applications. PureTech's leading team and board, along with an advisory network of more than 60 expert founder-scientists and advisors across multiple disciplines, gives PureTech access to potentially ground-breaking science and technological innovation. With healthcare undergoing major transformation, PureTech believes it is well positioned to develop and launch medicines for the 21st century. For more information, visit and connect with us on Twitter.

# # #


Julie DiCarlo, Senior Vice President, Communications & Investor Relations
+1 617 226 4819

FTI Consulting (Communications adviser to PureTech)
Ben Atwell
Matthew Cole
+44 (0) 20 3727 1000

This information is provided by RNS
The company news service from the London Stock Exchange



Record changed: 2017-07-02


Picture EBD Group BIO-Europe Spring 2019 BES Wien Partnering Opens 600x60px

More documents for PureTech Health (Group)

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]


Picture [LSUS] – The Business Web Portal 600x60px

» top